To the full analysis
Buyback calculator for TransMedics Group
TransMedics Group stock: key metrics
TMDXTransMedics Group had an operating margin of 17.9% and a return on invested capital (ROIC) of 25.1% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2016 | 12.3% | −370.2% | −387.6% |
| 2017 | 27.8% | −265.8% | −271.0% |
| 2018 | 44.1% | −155.5% | −182.5% |
| 2019 | 58.7% | −125.4% | −142.1% |
| 2020 | 64.9% | −102.9% | −112.1% |
| 2021 | 69.9% | −130.3% | −146.1% |
| 2022 | 69.8% | −33.6% | −38.8% |
| 2023 | 63.8% | −11.9% | −10.4% |
| 2024 | 59.4% | 8.5% | 8.0% |
| 2025 | 59.9% | 17.9% | 31.4% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2016 | −62.0% | −37.3% | −41.4% |
| 2017 | 12.3% | −42.2% | −56.3% |
| 2018 | 200.0% | −55.6% | −56.4% |
| 2019 | −61.4% | −39.4% | −31.9% |
| 2020 | −27.7% | −18.2% | −18.9% |
| 2021 | −65.2% | −24.7% | −32.8% |
| 2022 | −19.3% | −68.1% | −13.1% |
| 2023 | −18.2% | −14.5% | −3.5% |
| 2024 | 15.5% | 11.1% | 4.4% |
| 2025 | 40.2% | 25.1% | 17.8% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 23 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.